Friday, November 15, 2024
HomeTagsOsteoarthritis

osteoarthritis

Kolon Tissuegene Resumes TG-C Phase III Studies in the US

Kolon TissueGene, Inc., a leader in advanced cell and gene therapies, announced that it has resumed patient dosing in its U.S. Phase III study...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics